C-reactive protein (CRP) as it occurs in serum and in all but a very few pathological fluids is associated with a phosphorus-containing substance or substances of lipid character.' It can be obtained from the fraction of serum precipitable by 0.5 to 0.75 saturation with ammonium sulfate, following dialysis against dilute calcium chloride. The complex obtained by this procedure is insoluble in distilled water and in 0.85 per cent sodium chloride, but is completely soluble in a solution 0.1M in respect to both sodium chloride and sodium citrate. C-reactive protein rendered free of lipid-containing material is not precipitable by calcium ion alone, but does precipitate as a complex with the somatic C carbohydrate of pneumococcus in the presence of ionized calcium. The first crystallization of this protein was described by McCarty, who obtained it in crystalline form, containing no phosphorus, from two unusual serous fluids in which the protein existed unbound to lipid.' In McCarty's procedure, washed CRP-C carbohydrate complex, dissolved in a solution O.1M with respect to both sodium citrate and sodium chloride, was brought to 0.75 saturation with Na2SO4 and kept at 37°C. An amorphous precipitate formed and over a period of days gave rise to crystalline material. Crystalline CRP typically appears as flat rhomboid plates. Since both serum-associated lipid material and pneumococcal C carbohydrate contain phosphorus, it was evident from the elementary analysis of McCarty's two preparations that crystalline Creactive protein was free of both lipid and carbohydrate.
Wood, Slater and McCarty subsequently described a simple modification of method by which lipid-free, crystallizable CRP could be obtained.' Essentially this consisted of gently stirring concentrated CRP complex over chloroform in the cold several times. The defatted protein was then further purified and crystallized according to McCarty's original method.
There have been no published studies on the chemical or immunological properties of the "phospholipid" to which C-protein is bound in serum since the original one of MacLeod and Avery.' The present report describes some of the immunological characteristics of lipid-containing material which binds to CRP in serum and pathological fluids, and outlines another method for obtaining CRP suitable for crystallization. The reactivity of lipid-associated CRP with antisera to human beta lipoprotein, to be described in this report, has been independently observed by others.'
MATERIALS AND METHODS

Antiserum to C-reactive protein
Rabbit antiserum to C-reactive protein employed in this study was obtained from rabbits immunized by the intravenous route with lipid-free, non-crystalline CRP. The rabbits were given three successive courses of three daily injections of 0.5 mg. CRP. A five day rest period intervened between courses of injections. Estimations of CRP were made with rabbit antisera by capillary precipitin test.
Antisera to human beta lipoprotein
Goat, rabbit, and horse antisera to human beta lipoprotein were used to test for immunological reactivity of partially purified, "defatted," and crystallized preparations of C-reactive protein. The antigen employed in making these antisera was prepared by polyanion precipitation of pooled, normal human sera, further purified (to contain all materials of density 1.063 g/cc and less) by ultracentrifugation. The antisera were absorbed when necessary to remove antibodies to human serum components other than beta lipoprotein.'
Two of these antisera were used to remove the lipid-containing material from the three preparations of C-reactive protein which were crystallized.
Qne of these was a goat antiserum, the other horse.* Antiserum to C earbohydrate-precipitated lipid-associated CRP CRP was precipitated from a pool of 75 cc. of serum from patients with lymphomas by addition of 0.2 mg. of pneumococcal C carbohydrate. After two hours of incubation at 37°C. and overnight refrigeration, the proteincarbohydrate complex was recovered by centrifugation. The precipitate was washed three times in saline containing 0.01 per cent calcium chloride. The washed precipitate was redissolved in 10 cc. of a solution O.1M in respect to both sodium chloride and sodium citrate. A rabbit was immunized with this material by repeated intravenous injection.
Isolation of lipid-associated CRP C-reactive protein from three pools of starting material was isolated, purified and crystallized. The starting materials were: (1) 300 cc. of serous fluid from a patient with Hodgkin's Disease, (2) 150 cc. of pooled acute-phase sera from a number of patients, and (3) a second pool of 225 cc. of acute-phase serum. Fractionation of these preparations with ammonium sulfate was carried out.8 The lipid-C-reactive protein complex was obtained by dialysis of the "albumin fraction" against dilute calcium chloride.
Removal of lipid
The insoluble C-reactive protein was recovered by centrifugation, the supernate decanted, and the precipitate redissolved in 10 cc. of O.1M citrate-saline.
Removal of the material which formed an immune precipitate with antiserum to beta lipoprotein was accomplished by stepwise additions of antiserum to the preparations of CRP associated with lipid-containing material. A volume of antiserum equal to one-half the volume of the CRP preparation was added in each case. Immediate, copious precipitation occurred in all three instances. The preparations were incubated two hours at 370C. and refrigerated overnight. The immune precipitate was centrifuged out and twofold dilutions of the supernatant solution were set up in capillary precipitin tests with antiserum to CRP and with the antiserum to beta lipoprotein employed to "defat." In no instance, by this roughly quantitative method, did there appear to be loss of CRP, but in two of the three preparations there was residual weak reactivity with the antiserum to beta lipoprotein. This was completely removed by the further addition of appropriate amounts of the antiserum originally employed. The final solutions reacted strongly with antiserum to CRP but not at all with antisera to human beta lipoprotein.
Crystallization
Following treatment of the preparations with antiserum to human beta lipoprotein, pneumococcal C polysaccharide was added to the solution to precipitate C-reactive protein. The final concentration of C polysaccharide was approximately 0.1 mg/cc. After incubation at 370C. for two hours and refrigeration overnight, the precipitated protein-carbohydrate complex was recovered by centrifugation and washed three times with physiological saline containing 0.01 per cent calcium chloride. The washed complex was redissolved in a small volume of 0.1M citrate-saline solution. The protein solutions were brought to 0.75 saturation with a solution of sodium sulfate held at saturation at 370C. and placed in the incubator at 370C. In all three instances amorphous aggregates of roughly rhomboid shape appeared, and from these amorphous aggregations crystallization occurred.
Double diffusion in agar
Double diffusion studies in agar were carried out according to the method of Ouchterlony.' The medium consisted of 0.8 Difco Bactoagar in M/25 sodium barbital with 6 per cent glycine added. The final pH was adjusted to 7.7.
RESULTS
BEHAVIOR ON CRYSTALLIZATION
All three preparations of C-reactive protein crystallized in 0.75 saturated sodium sulfate held at 370C. The first preparation took 22 days to crystallize from the amorphous state, the second 17, and the third which was seeded with crystalline material from the first preparation, only 5 days. The crystals in all three preparations had a flat rhomboid form identical to that previously described. ' The crystalline CRP from the first preparation was used as antigen for the preparation of rabbit antiserum. The two antisera obtained gave no cross reaction with normal human serum but reacted with CRP in human serum and pathological fluids.
IMMUNOLOGICAL REACTIVITY OF CRYSTALLINE CRP
Capillary precipitin tests, using specific rabbit antiserum to CRP and six antisera to human beta lipoprotein, were done on twofold dilutions of each of the preparations which were crystallized, both before and following "defatting." Results obtained with one of the preparations are shown in Table 1 . Similar results were obtained with the two other preparations.
It is evident that the material giving immune precipitate with antibody to beta lipoprotein was precipitated from solution without co-precipitating any appreciable quantity of CRP. Removal of this material appeared to be complete.
PRECIPITATION REACTIONS WITH DOUBLE DIFFUSION IN AGAR
In order to study the immunological relationships between the lipidcontaining material associated with CRP, that of normal human serum, and that of acute-phase human serum, the technique of double diffusion in agar was employed. Figure 1 illustrates the reactions of horse antiserum to human beta lipoprotein with these three materials. A single band of precipitate was observed between this antiserum and all three test preparations. These three single bands gave reactions of identity indicating that the lipid-containing material which binds to CRP is present in normal human serum as well as in acute-phase human serum.
In order to test the specificity of the reactions between acute-phase human serum and antisera to beta lipoprotein and to CRP, acute-phase human serum was examined as shown in Figure 2 . Antiserum to human beta lipoprotein and antiserum to C-reactive protein each developed a single band of precipitate against acute-phase human serum. This same acutephase human serum gave four distinct precipitin bands with antiserum to with this technique one of these four bands represents antibody to beta lipoprotein and a second one antibody to CRP. These two antibodies in the antiserum to lipid-bound CRP give separate bands and provide reactions of identity respectively with antibody to human beta lipoprotein and with antibody to C-reactive protein.
DISCUSSION
Crystallization of CRP can be effected only when the protein is free of lipid material.8 In nature, CRP appears to occur without lipid or lipidcontaining substances only rarely. Thus, except in infrequent instances, some "defatting" procedure must be undertaken to render it crystallizable. The cumbersome and wasteful method of alcohol-ether extraction of lipid can be used.' A simpler and more practicable technique is to stir the concentrated lipid-associated C-protein over chloroform in the cold. Ap-lsolation of C-reactive protein I WOOD plication of this method has made it possible to obtain large amounts of CRP for physico-chemical characterization and for use as antigen.
In this paper, a third method has been described for rendering CRP free of lipid-containing substances and suitable for crystallization. This method, an immunological one, utilizes the reactivity of antibody to human beta lipoprotein with lipid-associated C-protein. By the criteria of immunological methods, the removal of lipid material appears to be complete. The characteristic precipitability of lipid-associated C-reactive protein by calcium ion is lost after adequate treatment with antibody to human beta lipoprotein. Apparently the lipid moiety is completely removed by the antibody, either as lipid or as lipoprotein. Since antibody to beta lipoprotein can quantitatively precipitate the lipid-containing component without appreciably diminishing the concentration of C-reactive protein in the supernate, it is probable that the bond between the two substances is a loose one, perhaps only a bridge of ionized calcium.
The three preparations of C-reactive protein which have been crystallized by the method described yielded crystals having the shape of rhomboid plates, which arose from aggregations of amorphous material in concentrated (0.75%o) sodium sulfate solution held at 37°C. Fine, small irregular needles, noted by McCarty on his initial crystallization of CRP, were not seen in the preparations crystallized by this new technique.
The immunological method described for lipid removal is not as practical as chloroform extraction, because the preparation of specific antiserum to human beta lipoprotein is complex, difficult and expensive.
SUMMARY
Antibody to human beta lipoprotein reacts with lipid-associated CRP to give immune precipitate. The antibody to the lipid-containing component is distinct from antibody to CRP.
Antibody to human beta lipoprotein does not react to form immune precipitate with purified CRP which has been crystallized.
CRP associated with lipid-containing material can be freed from lipid by using antibody to human beta lipoprotein. CRP thus "defatted" can be crystallized.
Specific antisera to lipid-free CRP and antisera to human beta lipoprotein each form a single band of antigen-antibody precipitate when reacted with human serum containing CRP in agar diffusion plates. The bands formed between such antisera and CRP-containing serum bear no apparent immunological relationship to each other.
